Newsroom

Verantos presents at DIA’s Real-World Evidence Conference 2024

Conferences

Verantos shared our expertise in RWD reliability and relevance alongside the FDA and Amgen at DIA RWE in the session, “Real-World Data Standards for Regulatory Submissions: Exploring the Challenges, Solutions, and Potential Alternatives.”

Read at the original outlet
All news
Get started

Ready to advance your evidence program?

Speak with our team about how the Verantos pharmacoepidemiology stack can accelerate your timeline.